DE602004031435D1 - Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus - Google Patents
Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virusInfo
- Publication number
- DE602004031435D1 DE602004031435D1 DE602004031435T DE602004031435T DE602004031435D1 DE 602004031435 D1 DE602004031435 D1 DE 602004031435D1 DE 602004031435 T DE602004031435 T DE 602004031435T DE 602004031435 T DE602004031435 T DE 602004031435T DE 602004031435 D1 DE602004031435 D1 DE 602004031435D1
- Authority
- DE
- Germany
- Prior art keywords
- hepatitis
- virus
- treatment
- heterocycles
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50206703P | 2003-09-11 | 2003-09-11 | |
PCT/US2004/027533 WO2005034850A2 (en) | 2003-09-11 | 2004-08-24 | Cycloalkyl heterocycles for treating hepatitis c virus |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004031435D1 true DE602004031435D1 (de) | 2011-03-31 |
Family
ID=34434839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004031435T Active DE602004031435D1 (de) | 2003-09-11 | 2004-08-24 | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus |
Country Status (7)
Country | Link |
---|---|
US (1) | US7112601B2 (de) |
EP (1) | EP1663105B1 (de) |
JP (1) | JP4897484B2 (de) |
AT (1) | ATE498398T1 (de) |
DE (1) | DE602004031435D1 (de) |
ES (1) | ES2358904T3 (de) |
WO (1) | WO2005034850A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT502258B1 (de) * | 2005-07-22 | 2007-09-15 | Univ Wien | Cox-i-inhibitorverbindungen |
US20070032488A1 (en) * | 2005-08-05 | 2007-02-08 | Genelabs Technologies, Inc. | 6-Membered aryl and heteroaryl derivatives for treating viruses |
KR20090042973A (ko) * | 2006-08-17 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 바이러스 폴리머라제 억제제 |
BRPI0808089A2 (pt) * | 2007-02-28 | 2014-07-15 | Conatus Pharmaceuticals Inc | Método para tratar uma doença do fígado, para diminuir um nível elevado de uma enzima do fígado, para inibir uma cascata de sinalização de tnf-alfa e uma cascata de sinalização de alfa-faz, para reduzir um dano ao fígado, para suprimir a apoptose excessiva em uma célula de fígado, e para inibir a replicação do vírus da hepatite c. |
WO2008106167A1 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
EP2494991A1 (de) | 2007-05-04 | 2012-09-05 | Vertex Pharmaceuticals Incorporated | Kombinationstherapie zur Behandlung von HIV-Infektionen |
US20110158908A1 (en) | 2007-08-24 | 2011-06-30 | Sapporo Medical University | Cyclosporin a-binding protein |
EP2234977A4 (de) | 2007-12-19 | 2011-04-13 | Boehringer Ingelheim Int | Viren-polymerasehemmer |
UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
AU2010203656A1 (en) | 2009-01-07 | 2011-07-21 | Scynexis, Inc. | Cyclosporine derivative for use in the treatment of HCV and HIV infection |
KR20140003521A (ko) | 2010-12-30 | 2014-01-09 | 이난타 파마슈티칼스, 인코포레이티드 | 페난트리딘 매크로사이클릭 c형 간염 세린 프로테아제 억제제 |
CN103534256B (zh) | 2010-12-30 | 2016-08-10 | 益安药业 | 大环丙型肝炎丝氨酸蛋白酶抑制剂 |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
US11724997B2 (en) | 2018-03-01 | 2023-08-15 | Annapurna Bio, Inc. | Compounds and compositions for treating conditions associated with APJ receptor activity |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9611047A (pt) * | 1995-10-17 | 2000-03-08 | Searle & Co | Processo de deteção de ciclo oxigenase-2 |
ATE298317T1 (de) | 1998-07-27 | 2005-07-15 | Angeletti P Ist Richerche Bio | Diketosäure-derivate als hemmstoffe von polymerasen |
WO2000010573A1 (en) | 1998-08-21 | 2000-03-02 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
CN1324250A (zh) | 1998-09-04 | 2001-11-28 | 维洛药品公司 | 治疗或预防病毒感染及其所致疾病的方法 |
JP2002525295A (ja) | 1998-09-25 | 2002-08-13 | バイロファーマ・インコーポレイテッド | ウイルス感染および関連疾患の治療または予防法 |
AU1324300A (en) * | 1998-10-26 | 2000-05-15 | Vertex Pharmaceuticals Incorporated | Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase |
AU1262001A (en) | 1999-11-04 | 2001-05-14 | Biochem Pharma Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
ID30204A (id) | 1999-12-27 | 2001-11-15 | Japan Tobacco Inc | Senyawa-senyawa cincin terfusi dan penggunaannya sebagai obat |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP1256628A3 (de) | 2001-05-10 | 2003-03-19 | Agouron Pharmaceuticals, Inc. | Hepatitis C Virus (HCV) NS5B RNA Polymerase und davon abgeleitete Mutanten |
EP2206709A3 (de) | 2001-06-11 | 2011-06-29 | Virochem Pharma Inc. | Thiophenderivate als antivirale Mittel gegen Flavivirus-Infektion |
AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
JP4558314B2 (ja) | 2001-07-20 | 2010-10-06 | ベーリンガー インゲルハイム (カナダ) リミテッド | ウイルスポリメラーゼインヒビター |
EP2335700A1 (de) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur |
WO2003026587A2 (en) | 2001-09-26 | 2003-04-03 | Bristol-Myers Squibb Company | Compounds useful for treating hepatitus c virus |
-
2004
- 2004-08-19 US US10/922,096 patent/US7112601B2/en active Active
- 2004-08-24 WO PCT/US2004/027533 patent/WO2005034850A2/en active Application Filing
- 2004-08-24 DE DE602004031435T patent/DE602004031435D1/de active Active
- 2004-08-24 EP EP04782095A patent/EP1663105B1/de active Active
- 2004-08-24 JP JP2006526121A patent/JP4897484B2/ja not_active Expired - Fee Related
- 2004-08-24 AT AT04782095T patent/ATE498398T1/de not_active IP Right Cessation
- 2004-08-24 ES ES04782095T patent/ES2358904T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
WO2005034850A3 (en) | 2006-03-16 |
ATE498398T1 (de) | 2011-03-15 |
EP1663105B1 (de) | 2011-02-16 |
WO2005034850A2 (en) | 2005-04-21 |
EP1663105A2 (de) | 2006-06-07 |
JP2007505114A (ja) | 2007-03-08 |
US7112601B2 (en) | 2006-09-26 |
EP1663105A4 (de) | 2009-04-15 |
JP4897484B2 (ja) | 2012-03-14 |
ES2358904T3 (es) | 2011-05-16 |
US20050075376A1 (en) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700338A1 (ru) | Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с и композиции и способы лечения с их использованием | |
ATE432922T1 (de) | Substituierte 5-carboxyamidpyrazoles und ä1,2, 4ütriazole als viruzide | |
DE602008004317D1 (de) | Verbindungen zur behandlung von hepatitis c | |
ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
ATE469155T1 (de) | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer | |
DK1987038T3 (da) | HCV NS5B-hæmmere | |
EA200802346A1 (ru) | Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с | |
CO5630024A2 (es) | Compuestos inhibidores de la hepatitis c | |
ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
TW200518746A (en) | Novel inhibitors of hepatitis C virus NS3/NS4A serine protease | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
TW200745120A (en) | Indolobenzazepine HCV NS5B inhibitors | |
WO2004002940A8 (en) | Inhibitors of hcv ns5b polymerase | |
EA200800371A1 (ru) | Ингибиторы ns3 протеазы вгс | |
WO2006012078A3 (en) | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection | |
MY164469A (en) | Hcv ns3 protease inhibitors | |
EA201001273A1 (ru) | Ингибиторы вируса гепатита с | |
JO2318B1 (en) | Nucleoside derivatives used as DNA-based viral RNA inhibitors | |
ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus | |
MX2012008443A (es) | Nucleosidos antiviricos. | |
DK2209789T3 (da) | Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere | |
ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
UA90909C2 (en) | Hcv ns3 protease inhibitors | |
ATE491706T1 (de) | Heterocyclische antivirale verbindungen |